ischemic retina
Recently Published Documents


TOTAL DOCUMENTS

32
(FIVE YEARS 0)

H-INDEX

13
(FIVE YEARS 0)

Author(s):  
Jose R. Hombrebueno ◽  
Aisling Lynch ◽  
Eimear M. Byrne ◽  
Gideon Obasanmi ◽  
Adrien Kissenpfennig ◽  
...  

Objective: Myeloid cells are critically involved in inflammation-induced angiogenesis, although their pathogenic role in the ischemic retina remains controversial. We hypothesize that myeloid cells contribute to pathogenic neovascularization in retinopathy of prematurity through STAT3 (signal transducer and activator of transcription 3) activation. Approach and Results: Using the mouse model of oxygen-induced retinopathy, we show that myeloid cells (CD45 + IsolectinB4 [IB4] + ) and particularly M2-type macrophages (CD45 + Arg1 + ), comprise a major source of STAT3 activation (pSTAT3) in the immature ischemic retina. Most of the pSTAT3-expressing myeloid cells concentrated at the hyaloid vasculature and their numbers were strongly correlated with the severity of pathogenic neovascular tuft formation. Pharmacological inhibition of STAT3 reduced the load of IB4 + cells in the hyaloid vasculature and significantly reduced the formation of pathogenic neovascular tufts during oxygen-induced retinopathy, leading to improved long-term visual outcomes (ie, increased retinal thickness and scotopic b-wave electroretinogram responses). Genetic deletion of SOCS3 (suppressor of cytokine signaling 3), an endogenous inhibitor of STAT3, in myeloid cells, enhanced pathological and physiological neovascularization in oxygen-induced retinopathy, indicating that myeloid-STAT3 signaling is crucial for retinal angiogenesis. Conclusions: Circulating myeloid cells may migrate to the immature ischemic retina through the hyaloid vasculature and contribute to retinal neovascularization via activation of STAT3. Understanding how STAT3 modulates myeloid cells for vascular repair/pathology may provide novel therapeutic options in pathogenic angiogenesis.



2020 ◽  
Vol 2 (4) ◽  
pp. 219-233 ◽  
Author(s):  
Valeria E. Lorenc ◽  
Raquel Lima e Silva ◽  
Sean F. Hackett ◽  
Seth D. Fortmann ◽  
Yuanyuan Liu ◽  
...  


JCI Insight ◽  
2020 ◽  
Vol 5 (6) ◽  
Author(s):  
Hongkwan Cho ◽  
Bria L. Macklin ◽  
Ying-Yu Lin ◽  
Lingli Zhou ◽  
Michael J. Lai ◽  
...  


2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Tea Soon Park ◽  
Ludovic Zimmerlin ◽  
Rebecca Evans-Moses ◽  
Justin Thomas ◽  
Jeffrey S. Huo ◽  
...  
Keyword(s):  


2019 ◽  
Vol 182 ◽  
pp. 144-155 ◽  
Author(s):  
Olivia E. O'Leary ◽  
Paul Canning ◽  
Emma Reid ◽  
Pietro M. Bertelli ◽  
Stuart McKeown ◽  
...  


2019 ◽  
Vol 33 (5) ◽  
pp. 6045-6054 ◽  
Author(s):  
Byung Joo Lee ◽  
Hyoung Oh Jun ◽  
Jin Hyoung Kim ◽  
Jeong Hun Kim
Keyword(s):  


eLife ◽  
2018 ◽  
Vol 7 ◽  
Author(s):  
Karina Kaczmarek-Hajek ◽  
Jiong Zhang ◽  
Robin Kopp ◽  
Antje Grosche ◽  
Björn Rissiek ◽  
...  

The P2X7 channel is involved in the pathogenesis of various CNS diseases. An increasing number of studies suggest its presence in neurons where its putative functions remain controversial for more than a decade. To resolve this issue and to provide a model for analysis of P2X7 functions, we generated P2X7 BAC transgenic mice that allow visualization of functional EGFP-tagged P2X7 receptors in vivo. Extensive characterization of these mice revealed dominant P2X7-EGFP protein expression in microglia, Bergmann glia, and oligodendrocytes, but not in neurons. These findings were further validated by microglia- and oligodendrocyte-specific P2X7 deletion and a novel P2X7-specific nanobody. In addition to the first quantitative analysis of P2X7 protein expression in the CNS, we show potential consequences of its overexpression in ischemic retina and post-traumatic cerebral cortex grey matter. This novel mouse model overcomes previous limitations in P2X7 research and will help to determine its physiological roles and contribution to diseases.





Oncotarget ◽  
2017 ◽  
Vol 8 (61) ◽  
pp. 103568-103580 ◽  
Author(s):  
Diana R. Gutsaeva ◽  
Menaka Thounaojam ◽  
Shubhra Rajpurohit ◽  
Folami L. Powell ◽  
Pamela M. Martin ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document